Jacobs Levy Equity Management, Inc Abb Vie Inc. Transaction History

Jacobs Levy Equity Management, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $12 Million - $16.2 Million	-148,694 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $6.91 Million - $8.11 Million	-80,409 Reduced 35.1%	148,694 $13 Million
Q2 2020 Aug 17, 2020	SELL	$73.37 - $98.18 $49.2 Million - $65.9 Million	-670,716 Reduced 74.54%	229,103 $22.5 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $16.5 Million - $25.1 Million	-256,525 Reduced 22.18%	899,819 $68.6 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $49.7 Million - $62.1 Million	688,492 Added 147.16%	1,156,344 $102 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $2.34 Million - $2.82 Million	-37,226 Reduced 7.37%	467,852 $35.4 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $14.7 Million - $18.7 Million	223,068 Added 79.1%	505,078 $36.7 Million
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $21.8 Million - $25.6 Million	282,010 New	282,010 $22.7 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.